BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 21 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $110,000 | +8.9% | 43,293 | +3.5% | 0.00% | – |
| Q3 2016 | $101,000 | 0.0% | 41,829 | +0.0% | 0.00% | – |
| Q2 2016 | $101,000 | -11.4% | 41,811 | -1.7% | 0.00% | – |
| Q1 2016 | $114,000 | -13.0% | 42,519 | -7.1% | 0.00% | – |
| Q4 2015 | $131,000 | +31.0% | 45,756 | +4.7% | 0.00% | – |
| Q3 2015 | $100,000 | -38.3% | 43,702 | -2.6% | 0.00% | – |
| Q2 2015 | $162,000 | – | 44,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 400,000 | $1,068,000 | 0.09% |
| SABBY MANAGEMENT, LLC | 493,191 | $1,317,000 | 0.07% |
| GUARDIAN CAPITAL ADVISORS LP | 10,000 | $23,000 | 0.00% |
| A.R.T. Advisors, LLC | 22,758 | $60,000 | 0.00% |
| Psagot Value Holdings Ltd. | 22,715 | $61,000 | 0.00% |
| TCI Wealth Advisors, Inc. | 1,100 | $3,000 | 0.00% |
| Penserra Capital Management LLC | 4,980 | $13,000 | 0.00% |
| D'Orazio & Associates, Inc. | 500 | $1,000 | 0.00% |
| CITIGROUP INC | 380 | $1,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,269 | $163,000 | 0.00% |